Adjuvant chemotherapy for primary cardiac sarcomas: the IGR experience.

The effect of additional treatments after surgery in patients with primary cardiac sarcoma (PCS) remains unknown. The present study aims to evaluate the benefit of chemotherapy in patients with non-metastatic cardiac sarcomas after optimal resection. Between October 1979 and December 1995, 15 patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Llombart-Cussac, A., Pivot, X., Contesso, G., Rhor-Alvarado, A., Delord, J. P., Spielmann, M., Türsz, T., Le Cesne, A.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group|1 1998
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063231/
https://www.ncbi.nlm.nih.gov/pubmed/9862574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063231/
https://www.ncbi.nlm.nih.gov/pubmed/9862574

Ejemplares similares